In the Netherlands, new cases of Parkinson’s disease occur more often in men, older adults, people with higher socioeconomic…
Articles by Margarida Maia, PhD
Mair Therapeutics is collaborating with Radboud University in the Netherlands to advance Parkinson’s disease research by developing small molecules…
Low muscle mass is more common in people with mild to moderate Parkinson’s disease than in those without the…
Aerobic exercise may help alleviate motor symptoms and reduce anxiety in early Parkinson’s disease, but there’s a chance…
A wrist-worn device may provide a clearer and more consistent picture of tremor in Parkinson’s disease than what can…
A $1.9 million U.S. Department of Defense–funded Phase 2 clinical trial will test SwallowFIT, a targeted exercise program designed to…
People with Parkinson’s disease have an increased abundance of the oral bacteria Streptococcus mutans — typically found in the…
Deep brain stimulation (DBS) can provide lasting relief from motor symptoms and help people with Parkinson’s disease function…
ARV-102, an oral therapy Arvinas is developing for people with Parkinson’s disease, was shown to reach the brain…
The oral therapy GT-02287, being developed by Gain Therapeutics for people with Parkinson’s disease with or without mutations…